Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram website >

January 31, 2019

Grant supports novel imaging initiative to enhance cancer care

A Vanderbilt initiative to develop predictive imaging technologies that clinicians can use to better match patients with personalized care has received National Cancer Institute (NCI) funding.

By Tom Wilemon
October 4, 2018

VICC’s Levy to lead Rush University Cancer Center

Mia Levy, MD, PhD, director of Cancer Health Informatics and Strategy at Vanderbilt-Ingram Cancer Center (VICC) and Ingram Associate Professor of Cancer Research, has been named director of Rush University Cancer Center and Systems Vice President for Cancer Service at Rush University Medical Center in Chicago.

By Tom Wilemon
May 17, 2018

Park named to VICC breast cancer leadership position

By Doug Campbell
trailer park
January 18, 2018

Study finds higher death rates in poor neighborhoods

Living in an economically disadvantaged neighborhood is likely to lead to death at an earlier age, especially among African-Americans, new research shows. The death rate is even more pronounced among disadvantaged individuals with unhealthy lifestyle habits.

By VUMC News and Communications
November 9, 2017

Mathis strives to make her cancer journey meaningful

Amanda Mathis, chief financial officer of Bridgestone Americas, was just 35 when she first felt a lump in her right breast.

By VUMC News and Communications
October 25, 2017

Vanderbilt-Ingram Cancer Center patients treated with new FDA-approved CAR-T therapy

Vanderbilt-Ingram Cancer Center has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR-T) therapy for treatment of adult patients with a specific type of lymphoma. VICC is the only cancer center in a seven-state region of the Southeast authorized to deliver the new immunotherapy.

By VUMC News and Communications
August 3, 2017

Investigators match novel cancer mutations with potential therapies

Research led by Vanderbilt-Ingram Cancer Center (VICC) investigators may have solved a mystery about why a targeted therapy stops working in a small group of breast cancer patients.
By VUMC News and Communications
June 8, 2017

Project reveals importance of cancer gene mutation testing

An international genomic data-sharing consortium has analyzed nearly 19,000 patient genomic records and found that testing of patient tumors for relevant gene mutations often provides a roadmap for the use of effective therapies.
By VUMC News and Communications
March 24, 2017

VUMC to offer free head and neck cancer screening April 7

A hoarse voice or persistent sore throat that lasts for weeks may seem like a mild nuisance, but those same symptoms could be early signs of head and neck cancer. To help patients determine their risk for disease and detect problems at an early stage, the Vanderbilt Department of Otolaryngology-Head and Neck Surgery and Vanderbilt-Ingram Cancer Center will offer free head and neck screenings Friday, April 7, from 9 a.m. to 3 p.m.
By VUMC News and Communications
February 2, 2017

National Cancer Institute’s Lowy details HPV virus research efforts

Douglas Lowy, M.D., acting director of the National Cancer Institute (NCI), warned that worldwide death rates from cervical cancer are expected to increase in low- and middle-income countries during the next 15 years unless steps are taken to prevent the cancer from occurring. Almost all cases of cervical cancer are linked to a viral infection.
By VUMC News and Communications
January 17, 2017

Vanderbilt-Ingram Cancer Center supports national HPV vaccination efforts

Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country.
By VUMC News and Communications
August 17, 2016

Chicken Salad Chick Foundation gift to support Vanderbilt-Ingram Cancer Center research

Chicken Salad Chick Foundation founding board members Stacy Brown and Betty and Earlon McWhorter presented a $200,000 check to Vanderbilt-Ingram Cancer Center (VICC) to support cancer research. Among other initiatives, the Chicken Salad Chick Foundation was proud to host Music and Miracles Superfest, the first major stadium concert in Jordan-Hare’s 75-year history, held on April 23 in Auburn, Alabama.
By VUMC News and Communications
May 19, 2016

VICC investigators in spotlight at AACR conference

A top Vanderbilt-Ingram Cancer Center (VICC) investigator recently met with Vice President Joe Biden regarding the National Cancer Moonshot Initiative, a major national program to identify, fund and accelerate the most promising research leading to cancer cures.
By VUMC News and Communications
1 … 20 21 22 23 24 … 28